Press release
Non-alcoholic steatohepatitis (NASH) Therapeutics & Diagnostics Market: Facts, Figures and Analytical Insights 2019- 2027|Industry Crucial Players - Siemens Healthcare GmbH (ETR: SHL), Celerion, ZyVersa Therapeutics, Inc., Cisbio
Research Nester
Further, for the in-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, market attractiveness, BPS analysis and Porter’s five force model.
The market for non-alcoholic steatohepatitis (NASH) therapeutics & diagnostics is projected to grow by a significantly high CAGR during the forecast period, i.e., 2019-2027. NASH is a fatty liver disorder caused by the accumulation of excessive amount of fat in the liver among people who consume little or no alcohol. The market is segmented by therapeutics, by diagnostics and by region, out of which, the therapeutics segment is further segmented into ocaliva, elafibranor, cenicriviroc, selonsertib and others. Out of these, the elafibranor segment is estimated to observe the highest growth as a result of high efficacy of this drug in serious cases of the disorder.
On the basis of regional analysis, the market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. Non-alcoholic steatohepatitis (NASH) therapeutics & diagnostics market in North America is anticipated to hold the leading share on account of rising technological advancements in the region. This can be attributed to the presence of leading market players in the region who are actively involved in research.
Get Sample PDF Copy of this Report @ https://www.researchnester.com/sample-request-2166
Rising Incidences of Obesity and Diabetes to Influence the Market Growth
According to the World Health Organization, about 1.9 billion adults (above the age of 18) were overweight and out of those, more than 650 million were obese in 2016.
The growing cases of obesity globally might lead to the development of non-alcoholic steatohepatitis, which is anticipated to raise the demand for effective therapeutic and diagnostic method, thereby increasing the market growth over the forecast period. However, the strict regulatory policies by the government and time-consuming process of clinical trials for drugs are estimated to hamper the market growth in the upcoming years.
This report also provides the existing competitive scenario of some of the key players of the global non-alcoholic steatohepatitis (NASH) therapeutics & diagnostics market which includes company profiling of Siemens Healthcare GmbH (ETR: SHL), Celerion, ZyVersa Therapeutics, Inc., Cisbio, Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), BioPredictive, Echosens, Genfit (EPA: GNFT), Enterome and NGM Biopharmaceuticals. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global non-alcoholic steatohepatitis (NASH) therapeutics & diagnostics market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.
To Know More About This Report Click Here @ https://www.researchnester.com/reports/global-non-alcoholic-steatohepatitis-nash-therapeutics-diagnostics-market/2166
Contact Us
AJ Daniel
Email: sales@researchnester.com
U.S. Phone: +1 646 586 9123
U.K. Phone: +44 203 608 591
About Research Nester
Research Nester is a one-stop service provider with a client base in more than 50 countries, leading in strategic market research and consulting with an unbiased and unparalleled approach towards helping global industrial players, conglomerates and executives for their future investment while avoiding forthcoming uncertainties. With an out-of-the-box mindset to produce statistical and analytical market research reports, we provide strategic consulting so that our clients can make wise business decisions with clarity while strategizing and planning for their forthcoming needs and succeed in achieving their future endeavors. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Non-alcoholic steatohepatitis (NASH) Therapeutics & Diagnostics Market: Facts, Figures and Analytical Insights 2019- 2027|Industry Crucial Players - Siemens Healthcare GmbH (ETR: SHL), Celerion, ZyVersa Therapeutics, Inc., Cisbio here
News-ID: 1895751 • Views: …
More Releases from Research Nester Pvt Ltd
Lutein and Zeaxanthin Market - Key Players, Capability Assessment & M&A Indicato …
The lutein and zeaxanthin market has expanded steadily as demand for eye-health supplements, functional foods, and preventive nutrition increases across global consumer segments. Lutein and zeaxanthin, two essential carotenoids concentrated in the retina, are widely recognized for their protective roles against oxidative stress, age-related macular degeneration (AMD), blue-light exposure, and general visual fatigue. Their adoption has accelerated with the rise of digital lifestyles, an aging population, and growing clinical evidence…
Top Companies in Atrial Fibrillation Market - Benchmarking Performance & Future …
The atrial fibrillation market is undergoing a period of rapid transformation as diagnostic technologies, catheter-based therapies, and antiarrhythmic solutions continue to advance. Atrial fibrillation (AFib) is one of the most prevalent cardiac arrhythmias globally, prompting significant demand for improved detection, early intervention, and minimally invasive treatment. The shift toward advanced ablation systems, AI-enabled diagnostics, wearable monitoring, and next-generation electro-mapping tools has strengthened competition across the market. Companies are expanding their…
Conductive Textiles Market - Top Companies, SWOT Deep Dive & Capital Flow Trends
The conductive textiles market is undergoing a rapid transformation as wearable electronics, smart apparel, and advanced sensor-integrated fabrics move from niche applications to mainstream adoption. Conductive textiles-engineered using conductive polymers, metal-coated fibers, or intrinsically conductive yarns-have become integral to next-generation healthcare wearables, military gear, automotive interiors, and consumer smart devices. As industries push for lighter, flexible, and more energy-efficient electronic systems, conductive materials embedded within fabrics are emerging as a…
Global Osteosynthesis Devices Market: Top Companies, Market Share Rankings & Inv …
The osteosynthesis devices market continues to evolve as orthopedic care moves toward minimally invasive procedures, biologically compatible materials, and technology-enabled implants. These devices-ranging from plates and screws to intramedullary nails and fixation systems-are essential for treating fractures, deformities, and complex bone injuries. Companies operating in this space are adopting strategies centered around product innovation, clinical efficacy, and expansion into fast-growing regions. As trauma care volumes rise in both developed and…
More Releases for NASH
The Growing Demand For NASH Treatment Amid Obesity Epidemic: A Key Catalyst Acce …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Non-Alcoholic Steatohepatitis (NASH) Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size for non-alcoholic steatohepatitis (NASH) has seen a considerable expansion in the past few years. Its value is expected to rise from $4.5 billion in 2024 to $6.06 billion in 2025, marking…
Nonalcoholic Steatohepatitis (NASH) Market Massive Growth opportunity Ahead
Introduction
Nonalcoholic Steatohepatitis (NASH) is an advanced form of nonalcoholic fatty liver disease (NAFLD) characterized by fat accumulation in the liver along with inflammation and liver cell damage. If left untreated, NASH can progress to fibrosis, cirrhosis, liver failure, or hepatocellular carcinoma. Closely tied to the global obesity and diabetes epidemic, NASH has become a major healthcare burden, with millions affected worldwide and no widely approved curative therapy to date.
The NASH…
Non Alcoholic Steatohepatitis (NASH) Market Size to Hit $21,879 Million by 2028 …
According to our experience research team, Non Alcoholic Steatohepatitis (NASH) Market was valued at USD 1,569 Million in 2021, and the global Non Alcoholic Steatohepatitis (NASH) industry is projected to reach a value of USD 21,879 Million by 2028, at a CAGR of 60.4% during the forecast period 2022-2028
The report is focused on gaining various Non Alcoholic Steatohepatitis (NASH) market trends, dynamics, growth drivers, opportunities, weaknesses, strengths, and threats restraining…
NASH Market Insight and Landscape report
Report Snapshot:
NASH is one of the furthermost causes of liver disease worldwide and will probably emerge as the leading cause of end-stage liver disease in the coming years, with the disease affecting both adults and children. The epidemiology and demographic characteristics of NASH vary across different country level. Furthermore, individuals with NAFLD have a high frequency of metabolic comorbidities and could place a growing strain on health-care systems from their…
Nash releases debut EP 'She Don't Know'
London-based singer/songwriter Nash has released his debut EP She Don’t Know. Recorded at the legendary RAK Studios, She Don’t Know has the feel of 60s rock but with a modern twist, leaving the listener hooked throughout and wanting to come back for another listen. She Don’t Know’s leading single CK is an infectious number which is sure to be a hit for 2017.
Listening to the Beatles and Jack White growing…
Nash Technologies at GITEX/GULFCOMMS 2010
Harvey Nash subsidiary presents expert services to telecom operators in the Middle East, Africa and South Asia region
Nürnberg/Germany, 10th September 2010 – For the first time Nash Technologies will be present at GITEX/GULFCOMMS, the largest international trade event for mobile, fixed, IP and satellite communications for the Middle East, Africa and South Asia region, in Dubai from 17th to 21st October 2010 offering its telecom expert services. Nash Technologies will…
